JACS Operative Word Podcast November 2023: Episode 17


The purpose of the JACS Operative Word Podcast is to give listeners the opportunity to claim CME credit for time spent learning about recent articles published in JACS. This session is ideal for faculty, program directors, residents, and medical students. Learners will become more competent in current surgical literature and up-to-the-minute surgical research and techniques.   

Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more. 


Episode 17: Novel Form of Breast Intraoperative Radiation Therapy with CT-Guided High-Dose-Rate Brachytherapy: Interim Results of a Prospective Phase II Clinical Trial   

In this episode, Dr. Jamie Coleman is joined by Shayna Showalter, MD, from the University of Virginia School of Medicine, Charlottesville, VA. They discuss Dr Showalter’s recent study evaluating precision breast intraoperative radiation therapy (PB-IORT), which uses customized CT-based treatment plans for high-dose-rate (HDR) brachytherapy. Interim results show that PB-IORT has an acceptable breast cancer recurrence rate, minimal side effects, and excellent cosmetic outcomes.  

Disclosure Information: Drs. Coleman and Showalter have nothing to disclose.  


Picture of JACS Operative Word Podcast November 2023: Episode 17
  • $0.00

About this course

Faculty Credentials

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

Editorial Committee Disclosures

Timothy J. Eberlein, Editor-in-Chief - Nothing to disclose
Lillian Kao, Social Media Editor - Nothing to disclose
Dr. Dante Yeh Disclosures outside the scope of this work: Dr. Yeh receives author royalties from UpToDate, advisory panel/training honoraria from Takeda Pharmaceuticals, and advisory panel honoraria from Baxter, Eli Lilly, and Fresenius Kabi.
Dr. Jamie J. Coleman - Nothing to disclose

Speaker Disclosures

Dr. Jamie J. Coleman - Nothing to disclose

Dr. Shayna Showalter - Nothing to disclose


Learning Objectives

Upon completion, participants will be able to:

  • Gain improved understanding of the most up-to-date surgical literature and techniques.
  • Consider opportunities to apply new knowledge or skills gained to practice and/or patient care.



Target Audience

  • Practicing Surgeons

  • Physicians
  • Allied health professionals

CME Accreditation

Continuing Medical Education Credit Information


The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American College of Surgeons designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American College of Surgeons and ACGME Logos

CME Credit Claiming Information


ALL ATTENDEES MUST COMPLETE THE COURSE EVALUATION in order to claim a CME Certificate or a Certificate of Completion. The course evaluation will appear once you take and complete this course. The following requirements will need to be completed:

  • Review all course materials
  • Complete course evaluation

Participants may only claim a maximum of 0.25 AMA PRA Category 1 Credits™ per episode for the JACS Operative Word Podcast. CME credit for each episode can be claimed for up to two years after the original air date.